Hinge Health (NYSE:HNGE) Major Shareholder Insight Holdings Group, Llc Sells 181,499 Shares

Hinge Health Inc. (NYSE:HNGE) major shareholder Insight Holdings Group, Llc sold 181,499 shares of the business’s stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $90.20, for a total transaction of $16,371,209.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Insight Holdings Group, Llc also recently made the following trade(s):

• On Tuesday, July 7th, Insight Holdings Group, Llc sold 244,672 shares of Hinge Health stock. The stock was sold at an average price of $90.23, for a total transaction of $22,076,754.56.
• On Thursday, June 25th, Insight Holdings Group, Llc sold 530,982 shares of Hinge Health stock. The shares were sold at an average price of $71.82, for a total transaction of $38,135,127.24.
• On Monday, June 29th, Insight Holdings Group, Llc sold 1,466,667 shares of Hinge Health stock. The stock was sold at an average price of $82.83, for a total value of $121,484,027.61.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The stock was sold at an average price of $71.67, for a total value of $10,199,429.37.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The shares were sold at an average price of $71.15, for a total transaction of $27,813,744.55.
• On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The stock was sold at an average price of $70.21, for a total value of $7,897,010.17.
• On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The shares were sold at an average price of $70.95, for a total value of $15,921,109.05.
• On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total value of $4,614,279.16.

Hinge Health Price Performance

Shares of Hinge Health stock opened at $89.95 on Friday. The stock has a market capitalization of $6.96 billion, a price-to-earnings ratio of -7.29 and a beta of 1.13. The business has a 50-day moving average of $64.48 and a 200 day moving average of $49.91. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $91.07.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The company had revenue of $182.31 million for the quarter. During the same quarter last year, the company earned $1.30 earnings per share. The firm’s revenue for the quarter was up 47.2% on a year-over-year basis. Equities research analysts anticipate that Hinge Health Inc. will post 1.33 earnings per share for the current year.

Hedge Funds Weigh In On Hinge Health

Several hedge funds and other institutional investors have recently modified their holdings of HNGE. BIT Capital GmbH lifted its position in Hinge Health by 79.3% during the fourth quarter. BIT Capital GmbH now owns 3,316,101 shares of the company’s stock valued at $154,033,000 after buying an additional 1,466,577 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Hinge Health by 110.5% in the fourth quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company’s stock worth $121,027,000 after acquiring an additional 1,367,693 shares in the last quarter. Tiger Global Management LLC grew its position in shares of Hinge Health by 227.1% during the fourth quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company’s stock worth $83,877,000 after buying an additional 1,253,743 shares in the last quarter. Marshall Wace LLP acquired a new position in Hinge Health during the 4th quarter worth $54,469,000. Finally, Millennium Management LLC increased its holdings in shares of Hinge Health by 225.0% in the 4th quarter. Millennium Management LLC now owns 1,479,642 shares of the company’s stock valued at $68,729,000 after acquiring an additional 1,024,317 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Wells Fargo & Company increased their price objective on Hinge Health from $80.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Citigroup restated an “outperform” rating on shares of Hinge Health in a research report on Wednesday, May 6th. Weiss Ratings upgraded shares of Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 6th. Canaccord Genuity Group increased their target price on Hinge Health from $65.00 to $76.00 and gave the stock a “buy” rating in a research note on Monday, June 15th. Finally, Wall Street Zen cut shares of Hinge Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 6th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $75.80.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.